The global Blood Collection Devices Market, valued at US$8.61 billion in 2024, has climbed to US$9.13 billion in 2025, setting the stage for robust expansion. With a projected CAGR of 7.4% from 2025 to 2030, the market is on track to reach US$13.02 billion by 2030—signaling a period of sustained innovation and rising worldwide demand for accurate, safe, and efficient blood collection technologies.
Today, blood collection lies at the heart of diagnostics, therapeutic monitoring, public health surveillance, and clinical research—making it one of the most indispensable components of modern healthcare.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=689
What’s Fueling the Rapid Growth of the Blood Collection Devices Market?
1️⃣ Infectious & Chronic Diseases Continue to Surge
Rising rates of diabetes, cardiovascular diseases, cancer, and infectious conditions are significantly increasing the need for frequent and reliable blood testing globally. Preventive care and wellness programs are also boosting routine diagnostics.
2️⃣ Growth of Hospitals, Surgical Centers & Trauma Care
With the expansion of healthcare infrastructure, especially in Asia Pacific, the demand for reliable blood collection devices—tubes, syringes, bags, and automated systems—is accelerating.
Additionally, rising accident and trauma cases are driving the need for quick blood sampling for emergency diagnostics.
3️⃣ Liquid Biopsy Revolution
The market is experiencing tailwinds from the rapid adoption of liquid biopsy tests for early cancer detection, therapy selection, and disease monitoring.
This trend requires high-integrity sample collection tubes that maintain analyte stability—opening new avenues for innovation.
4️⃣ Rising Blood Donations & Transfusion Needs
Growing awareness around blood donation, along with national programs for plasma and component collection, is expanding demand for blood bags, apheresis systems, and automated collection devices across emerging regions.
Market Breakdown: Key Segments Driving Revenue
By Product: Blood Collection Tubes Lead the Market
In 2024, blood collection tubes held the largest market share, driven by:
- Versatility for multiple diagnostic tests
- Use of additives for clotting or anticoagulation
- Standardization requirements in hospitals, labs, and blood banks
- Compatibility with modern automated analyzers
With diagnostic accuracy becoming increasingly critical, demand for advanced, contamination-free, and safety-valve blood collection tubes continues to rise.
By Application: Diagnostics Dominate in 2024
Diagnostic applications accounted for the dominant share due to:
- Rising chronic disease cases
- Higher volume of routine health check-ups
- Explosion of preventive and personalized healthcare
- Integration of automated blood collection systems
- Increasing focus on timely, accurate, and standardized sample handling
Advancements in automated phlebotomy, AI-driven testing, and digital sample tracking are expected to further strengthen this segment.
Regional Insights: North America Leads the Way
North America—especially the US—continues to hold the largest share in 2024, backed by:
- High prevalence of lifestyle diseases
- Strong adoption of diagnostic technologies
- Presence of leading manufacturers
- Advanced healthcare infrastructure
- Strong reimbursement environment
Europe follows as the second-largest market, while Asia Pacific is emerging as the fastest-growing region, fueled by expanding hospital networks, improved diagnostic access, and rising awareness about blood safety.
Leading Companies Shaping the Blood Collection Devices Market
1️⃣ Fresenius Kabi AG (Germany) – Market Leader
Fresenius continues to dominate the blood bags and consumables segment with:
- Strong global distribution
- Growing automation in manufacturing
- Sustainability-driven initiatives
- Expanding presence in Asia Pacific and Latin America
2️⃣ Becton, Dickinson and Company (US)
BD’s portfolio spans Vacutainer tubes, syringes, needles, lancets, and now next-gen capillary blood collection devices.
Recent highlights include:
- FDA clearance (2023) for a novel fingerstick device offering laboratory-grade results
- Expansion of BD MiniDraw across US pharmacies
- A focus on digital health integration and patient comfort
3️⃣ Terumo BCT, Inc. (US/Japan)
A global leader in apheresis systems with strong innovation capabilities.
Recent developments:
- Launch of Intercept 10 Platelet System (2024)
- Expansion of manufacturing facilities in the US and Costa Rica
- Investment in digital blood management and cell therapy platforms
Latest Trends Defining the Future (2025–2030)
Trend 1: Shift Toward Minimal-Invasive & Capillary Collection
Fingerstick and microneedle-based sampling are gaining traction for home testing and retail clinics.
Trend 2: Automation & Robotic Phlebotomy
Robotic systems and automated collection monitors reduce human error and enhance blood safety.
Trend 3: AI & Digital Integration
Digital tracking, barcode-enabled tubes, and AI-driven sample handling are becoming the new norm.
Trend 4: Safety-Engineered Devices
Growing demand for safety needles, closed systems, and sharps injury prevention in hospitals.
Trend 5: Rise of Personalized Healthcare
Genomics, oncology, and precision medicine require more frequent and high-quality blood sampling.
Conclusion: The Blood Collection Devices Market Is Entering a High-Innovation Era
As diagnostics, personalized medicine, and patient-centered care continue to grow worldwide, the blood collection devices market is evolving from traditional tools to smart, automated, and highly precise systems. With rising disease burden, emerging technologies, and global emphasis on blood safety, the industry is set for a strong and sustained growth phase through 2030.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=689
